Inventor
POLO JOHN M
US22 patents
⚠️ This page may combine multiple inventors who share the name “POLO JOHN M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CHIRON CORP
12 patentsUS6342372B1Jan 29, 2002
Eukaryotic layered vector initiation systems for production of recombinant proteins
CHIRON CORP90 citations99
US6376236B1Apr 23, 2002
Recombinant alphavirus particles
CHIRON CORP121 citations98
US5843723ADec 1, 1998
Alphavirus vector constructs
CHIRON CORP327 citations98
US5789245AAug 4, 1998
Alphavirus structural protein expression cassettes
CHIRON CORP345 citations98
US6329201B1Dec 11, 2001
Compositions and methods for packaging of alphavirus vectors
CHIRON CORP86 citations97
US6015694AJan 18, 2000
Method for stimulating an immune response utilizing recombinant alphavirus particles
CHIRON CORP228 citations97
US6465634B1Oct 15, 2002
Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
CHIRON CORP45 citations96
US6451592B1Sep 17, 2002
Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
CHIRON CORP50 citations96
US6426196B1Jul 30, 2002
Alphavirus structural protein expression cassettes
CHIRON CORP57 citations96
US6391632B1May 21, 2002
Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
CHIRON CORP63 citations96
US6767699B2Jul 27, 2004
Method for the quantitation of alphavirus replicon particles
CHIRON CORP50 citations92
US6458560B1Oct 1, 2002
Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
CHIRON CORP37 citations90
NOVARTIS VACCINES & DIAGNOSTIC
6 patentsUS7977091B2Jul 12, 2011
Eukaryotic layered vector initiation systems
NOVARTIS VACCINES & DIAGNOSTIC38 citations96
US7811812B2Oct 12, 2010
Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
NOVARTIS VACCINES & DIAGNOSTIC43 citations94
US7744900B2Jun 29, 2010
Enhancement of the immune response for vaccine and gene therapy applications
NOVARTIS VACCINES & DIAGNOSTIC20 citations92
US7572628B2Aug 11, 2009
Eukaryotic layered vector initiation systems
NOVARTIS VACCINES & DIAGNOSTIC9 citations92
US7572453B2Aug 11, 2009
Chimeric alphavirus replicon particles
NOVARTIS VACCINES & DIAGNOSTIC18 citations91
US7531180B2May 12, 2009
Chimeric alphavirus replicon particles
NOVARTIS VACCINES & DIAGNOSTIC15 citations91